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586: Use of natural analogs as AchE inhibitor
for treatment of early stage Alzheimer’s Disease
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3Zahra Hassan, 4Kumar H. S. Jeevan, 4M. Suresh,
4M. D. Saleem Farooqi
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2Dept of Pharmacology, Yale University, United States of America,
3Mohammad Ali Jinnah University, Rawalpindi, Pakistan,
4Dept of Biotechnology, New Horizon College, Banglore, India
Alzheimer’s disease (AD) is a progressive neurodegenerative disease
that, in its most common form, occurs as dementia in people over
65 years old although early onset form also exists. Currently it afflicts
24 million people worldwide. The disease is characterized in the brain
by abnormal clumps (amyloid plaques) and tangled bundles of fibers
(neurofibrillary tangles) composed of misplaced proteins. Three neu-
rotransmitters commonly affected by AD are acetylcholine, serotonin,
and nor epinephrine. The cholinergic system—the nerve cell system in
the brain that uses acetylcholine as a neurotransmitter—is the most
dramatic of the neurotransmitter systems affected by Alzheimer’s
disease. Acetylcholinesterase is one of the most crucial enzymes that
hydrolyze acetylcholine in the brain to choline and acetic acid at
cholinergic synapses, leading to nerve response and function. Poten-
tiation of central cholinergic activity has been proposed as a therapeutic
approach for improving the cognitive function in patients with Alz-
heimer’s disease (AD). Increasing the acetylcholine concentration in
the brain by modulating/inhibiting acetylcholinesterase (AchE) activ-
ity is among the most promising therapeutic strategies. In our studies
attempts were made to produce potential natural acetylcholinesterase
inhibitors. More than eight hundred compounds were taken from dif-
ferent natural sources. Initial in-silico screening of molecules was
based on docking score between acetylcholinesterase and compounds
taken from the natural sources. The hits were further analyzed and
narrowed by applying Lipinski’s rule-of-five analysis. Molecules with
high ability to cross blood brain barrier were taken for energy mini-
mization and quantitative structure activity studies. The biological
activity of promising compounds was predicted by using PASS pre-
diction analysis. Ferulic acid and Caffeic acid found in garlic showed
very good IC50 values and satisfied the standard drug-like properties
with remarkable pharmacokinetics and pharmacodynamics abilities.
Thus we hypothesize that ferulic acid and caffeic acid which is obtained
from garlic can be used as an effective acetylcholinesterase inhibitors
in the early stage of Alzheimer’s disease. Wet lab studies were con-
ducted on the Swiss Albino mice as the animal model to check the
inhibition of acetycholinestrerase by ferulic acid and caffeic acid.
587: Challenges and opportunities in the post-genomic
chemical biology age: The hunt for small molecule,
chemical dissectors of signaling networks
1,2Prabhat Arya
1Ontario Institute for Cancer Research, MaRS Centre, South Tower,
101 College Street, Toronto, Ontario, M5G 0A3, Canada,
2Steacie Institute for Molecular Sciences, NRCC, 100 Sussex Drive,
Ottawa K1A 0R6, Canada
The research in our group aims at developing methods leading to high-
throughput generation of natural product-inspired compounds with the
goals of identifying chemical modulators of protein–protein interac-
tions-based dynamic signaling pathways. In addition to utilizing these
compounds in a wide variety of solution cellular assays, they are also
utilized in printing small molecule microarrays (SMM) in collabora-
tion with the chemical biology team at the Broad Institute. The use of
the SMM technology is highly attractive in performing high-
throughput small molecule–protein binding studies. Over the years,
although the high-throughput synthetic approaches have been very
successful in generating a large number of small molecules but in most
cases, these compounds are simple in nature and thus lack the features
that are commonly found in bioactive natural products (i.e., 3D
architectures, rich in chiral display of dense functional groups etc).
Our team is working on the hypothesis that small molecules being
generated from our program are highly likely to exhibit better bio-
logical responses (e.g., as modulators of protein-protein interactions
etc.) because these compounds are anticipated to occupy the chemical
space being championed by bioactive natural products known to
modulate p–p interactions. Through working in collaboration with the
biomedical (including the NMR structural biology) community
involved in programmed cell death pathways (e.g., Bcl-2 family,
Caspases, XIAPs etc) and in kinases and phosphatases signaling,
several novel functional chemical probes have been identified to date.
Our work in this direction will be presented in this poster/short talk.
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588: S29 ribosomal protein regulates balance between
cell death and survival in Hep2 cells through MAPK/
mitochondrial pathway
1Jyoti Balhara, 1Ravindresh Chhabra, 1Yogita Malik, 1Richa Singh,
2Neeta Singh, 1Neeru Saini
1Institute of Genomics and Integrative Biology, Mall Road, Delhi
110007, India, 2Dept. Of Biochemistry, All India Institute of Medical
Sciences, New Delhi 110029, India
Multifunctionality of proteins is one of the mechanisms accounting for
the complexity of interactome networks in higher eukaryotes. There are
various reports in the literature which suggest that during oncogenesis
and other pathologic conditions many proteins perform additional
functions without changes in three dimensional structures. One such
multifunctional protein is S29 ribosomal protein. The S29 ribosomal
protein is not only involved in ribosome assembly but its enhanced
expression has been shown to possess antitumor properties in non small
cell lung cancer H520 cells. Literature also suggest that S29 ribosomal
protein increases tumor suppressor activity of RAP1A (Krev-1) gene
on v-K ras-transformed NIH3T3 cells. Recently conservation and
multifunctional nature of ribosomal protein S29 has considerably
drawn the attention of researchers so that basic mechanism behind its
function can be elucidated. Adopting biochemical and proteomic
approaches we made an attempt to investigate the antiproliferative
potential of S29 ribosomal protein on cultured Hep2 cells. Apoptosis
was examined by Hoechst 33342 staining, FACS, increased expression
of pro-apoptotic protein Bax, decreased expression of anti-apoptotic
proteins Bcl-2 and Bcl-XL, release of apoptogenic cytochrome c and
activation of initiator caspase-8, -9 and effector caspase-3 followed by
cleavage of nuclear substrate poly (ADP-ribose) polymerase. There
was also non-involvement of p53 in S29 ribosomal protein induced
apoptosis and the pro-apoptotic effect was mediated by inactivation of
ERK, JNK and p38 MAPK. We further assessed whether S29 over-
expression could increase chemosensitivity of cancer cells to chemo-
therapeutic agents. Our results showed that S29 overexpression
increases Hep2 cells sensitivity to Cisplatin, Etoposide and TNF alpha;
but to different extents. Our proteomic results also confirmed the
proapoptotic role of S29. For the first time, we report here the potential
of anti-human laryngeal activity of S29 ribosomal protein in Hep2
cells. This study also raises the possibility of S29 ribosomal protein as a
promising approach to cancer therapy.
589: The effects of humanin peptides on mitochondrial
functions and global gene expression
Marek Bodzioch, Katarzyna Lapicka-Bodzioch, Barbara Zapala,
Aldona Dembinska-Kiec
Department of Clinical Biochemistry, Collegium Medicum,
Jagiellonian University, Kopernika 15a, 31501 Krakow, Poland
Backgroud: Humanin (HN) is a novel antiapoptotic and neuroprotec-
tive peptide. Using bioinformatic tools, we have recently identified a
host of putative nuclearly-encoded HN peptides.
Aim: To assess the biological properties of the synthetic nuclear HN
peptides.
Methods: Human umbilical vein endothelial cells (HUVECs) were
exposed to proapoptotic conditions triggering the BAX-related path-
ways (staurosporine or UV light) and incubated with different HN
peptides. Global gene expression changes were assessed by custom-
made Affymetrix NuGO chips, while mitochondrial function and
apoptosis were monitored in real-time by high-throughput fluorescence
confocal microscopy (BD Pathway Bioimager 855) using markers of
viable mitochondria (TMRM, JC-1) and active caspases (specific
labeled antibodies). Results: Among the studied peptides, significant
differences in antiapoptotic potential were found between the Thr13
and Ile13 izoforms (c.38C[T) of the HN10b. The wild-type threonine
izoform provided much stronger antiapoptotic activity then the iso-
leucine peptide. HUVECs treated with Ile13 HN10b succumbed
significantly quicker to staurosporine than those pre-incubated with
Thr13 HN10b as demonstrated by the rate of TMRM signal loss par-
alleled by the increase in caspase activation. Variable functional
properties of the Thr13 and Ile13 HN10b variants were also reflected by
differential global gene expression patterns.
Conclusion: The nuclearly-encoded HN peptides may differ in their
antipoptotic potential, which is especially apparent when comparing
the Thr13 and Ile13 variants of HN10b.
590: Novel paradigm in lipid metabolic network
of Mycobacterium tuberculosis
Tarun Chopra, Debasisa Mohanty, Rajesh S. Gokhale
National Institute of Immunology, Aruna Asaf Ali Marg, India
Mycobacterium tuberculosis (Mtb) is the etiologic agent of tubercu-
losis and infects approximately 32% of the human population. The cell
envelope of mycobacteria is endowed with a number of unique lipids
that play an important role in its virulence. Large multifunctional
proteins called polyketide synthases (PKSs) catalyze the biosynthesis
of these lipids. PKSs are generally involved in the synthesis of sec-
ondary metabolites in various organisms and their role in biosynthesis
of virulence factors is unprecedented. PKSs require proteins called
fatty acyl AMP ligases for the activation and utilization of fatty acid
substrates. PKS12 is the largest open reading frame in the Mtb genome
and contains at least twelve different catalytic sites on a single protein.
Our systematic investigation of PKS12 protein revealed formation of a
novel supramolecular assembly that catalyzes biosynthesis of a
mycobacterial phospholipid antigen. Clearly, the lipid repertoire of
mycobacteria necessitates a coordinated network of various biosyn-
thetic enzymes. Insights into these molecular events provide an
opportunity to develop inhibitors that would simultaneously disrupt
several pathways in lipid metabolism. Due to overlapping substrate
specificities and cofactor requirements of various enzymes involved in
lipid biosynthesis, directed synthesis of chemical compounds targeting
multiple pathways could provide new avenues for drug discovery.
591: Novel RNAi-based chemical genetic screen
to identify small molecule modulators of the Wnt/wg
signaling pathway
Foster Gonsalves, Ramanuj DasGupta
NYU School of Medicine—Cancer Institute, 522 First Avenue,
Smilow 1107, New York, NY 10016, United States of America
Recent advances in functional and chemical genomics have led to vast
advances in both, the understanding of disease and the potential to
discover effective therapeutics to combat otherwise intractable disease
states such as cancer. The Wnt/wingless (wg) pathway is one of a core
set of evolutionarily conserved signaling pathways that regulates many
aspects of development and homeostasis. Misregulation of the Wnt
pathway can be detrimental since mutations in several components are
associated with tumorigenesis of the breast, liver, colon, and the skin. It
is therefore crucial to develop and implement new technologies in
order to generate molecular tools that may be used to modulate the
activity of the Wnt/wg signaling pathway. One of the key effectors of
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the Wnt pathway is encoded by beta-catenin (B-cat). Induction by Wnt
ligands leads to stabilization of cytosolic B-cat, which subsequently
translocates to the nucleus to activate target genes that regulate many
aspects of cell proliferation, growth, differentiation and death. Since
Catenin Responsive Transcription (CRT) has been implicated in the
genesis of many cancers, it makes a good target for developing ther-
apeutics that could modulate the nuclear activity of B-cat. Recently, we
employed a novel methodology of integrating a ‘sensitized’ chemical
genetic high-throughput screen (HTS) with RNA-interference (RNAi)
screening technology in order to identify specific small molecule
inhibitors of the Wnt pathway in Drosophila cells. The primary screen
was performed in Drosophila derived Clone 8 cells, which afforded the
advantage of a non-redundant genome. Subsequent secondary screens
were performed in mammalian cell lines including the mouse mam-
mary epithelial cell line, C57 mg; human epithelial cell line, HEK 293;
the colon-cancer cell line, HCT-116; and the breast cancer cell line,
MCF-7. Each of the aforementioned cell types is Wnt responsive and
thus allowed for heterologous systems to validate the efficacy of the
compounds on Wnt-signaling. We envisage that compounds identified
in ours and similar future screens will serve as prototypes for the
development of anti-tumor drugs targeted to B-cat responsive tran-
scriptional programs involved in different cancers. Furthermore, this
study paves the way for the development and implementation of a new
technological advance for rapid screening of large compound libraries
to identify modulators of specific signaling pathways.
592: TRIM69/HSD34 protein, a RING finger protein,
functions as an E3 ligase in regulating cell cycle
and apoptosis by interacting with HUS1 protein
1Yongqing Han, 1Hongyu Wu, 1Rong Li, 2Shudong Zong,
1Shiying Miao, 1Linfang Wang
1National Laboratory of Medical Molecular Biology, Institute of
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University, 5 Dong Dan San Tiao, Beijing 100005, China, 2National
Research Institute for Family Planning, WHO Collaborating Center
for Research in Human Reproduction, Beijing 100081, China
Trim69/Hsd34 is a novel gene discovered in our laboratory by studying
human primary spermatocytes by the combined use of the techniques of
laser capture microdissection (LCM) with suppressive subtractive
hybridization (SSH). The gene coded protein (TRIM69 protein) con-
sists of an N-terminal RING finger, followed by a B-box zinc finger, a
coiled-coil domain, and a B30.2 domain. A class of E3 ligase family
consists of proteins containing RING finger domain that are involved in
ubiquitin-dependent proteasome system. Thus based on its sequence,
TRIM69/HSD34 protein is proposed to an ubiquitin ligase. In vivo
ubiquitination assay showed that TRIM69 protein could transfer
ubiquitin to itself, whereas a point mutant of RING finger domain failed
to mediate this action. Moreover, subcellular localization of those
mutants of TRIM69 protein without the RING domain changed from
speckled around the nucleus to scattered specks in the cytoplasm. Thus
the RING finger domain may play an important role both in TRIM69
protein auto-ubiquitination and its intracellular localization. This auto-
ubiquitination may be an auto-regulatory mechanism and target itself
for ubiquitin-dependent degradation or a modification process of its
biological activity. HUS1 protein has been demonstrated to be capable
of interacting with TRIM69 protein based on the yeast two-hybrid
assay. The interaction was validated by a Co-immunoprecipitation
assay. Immunofluorescence assay showed colocalization of TRIM69
protein with HUS1 protein. The above-mentioned data suggest that
HUS1 protein might be a substrate of TRIM69 protein. HUS1 protein is
known to function as a DNA damage sensor together with RAD9 and
RAD1 proteins by forming RAD9-HUS1-RAD1 (9-1-1) complexes.
Therefore, TRIM69 protein may be involved in cell cycle regulation
and apoptosis by interacting with HUS1 protein. Since HUS1 protein
exists in association with RAD1 and RAD9 proteins, it is pertinent and
of interest to determine the functional relationship of TRIM69 protein
with RAD1 and RAD9 proteins.
593: Potentiation of macrophage function by cigarette
smoke against Leishmania donovani infection
1Palash Maity, 2Surojit Bhattacharjee, 2Subrata Majumdar, 1Alok Sil
1University of Calcutta, Department of Microbiology, UCSTA,
35 B. C. Road, Kolkata 700019, India, 2Bose Institute, Department of
Microbiology, Bose Institute, P1/12 CIT Scheme VIIM,
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Background: Macrophages play important role in host defense by
producing cytotoxic products, including reactive oxygen species
(ROS), to kill invading organisms. They also generate cytokines,
chemokines and immunomodulators that are involved in inflamma-
tory response and cell mediated immunity. Despite these activities
intracellular parasites, such as Leishmania, reside within the macro-
phage. They lower the level of ROS inside macrophage, and
manipulate cellular signaling processes involved in host cell immune
response, such as NF-jB, in their favour. Since cigarette smoke (CS)
contains numerous oxidants and is able to induce pro-inflammatory
cytokines, we examined its macrophage activation property by
examining cellular parasite burden, ROS level, cytokine expression
pattern and NF-jB signaling in Leishmania donovani (L. donovani)
infected peritoneal macrophages.
Methods: Cultured peritoneal macrophages were either left untreated
or treated with aqueous cigarette smoke extract (CSE) prior to
L. donovani infection. Parasite burden was assessed by giemsa staining
of infected cells. In vivo parasite burden was assessed by looking at the
giemsa stained spleen sections obtained from either CS-unexposed or
CS-exposed L. donovani infected BALB/c mice. Intracellular ROS
level was determined by FACS analysis using DCFH-DA. Semi-
quantitative RT-PCR and quantitative real time PCR were performed to
analyze mRNA levels of cytokines. NF-jB activity was assessed by
EMSA and reporter assay.
Results: Our results show that a restricted dose of CS and CSE limit
leishmanial parasitic burden in mouse and in vitro cultured peritoneal
macrophage cells respectively, without exhibiting cellular cytotoxic-
ity. A pre-treatment with CSE causes an increase in intracellular ROS
level, up-regulates the generation of pro-inflammatory cytokines,
lowers the expression of immuno-suppressive cytokine and boosts
NF-jB activity in L. donovani-infected macrophage.
Conclusion: Low concentration of CSE counteracts L. donovani
infection-mediated suppression of macrophage function without
affecting host cell viability. This study reveals a new role of CSE as
an activator of macrophage function.
594: Novel mutations in sarcomeric and desmosomal
genes in cardiomyopathies—An Indian study
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Cardiomyopathies, a group of disorders characterized by malfunc-
tioning of the myocardium and clinically identified by heart failure,
arrhythmias and sudden death. The Indian population is considered to
be at greater risk for cardiovascular diseases with high mortality.
Based on the pathophysiology, cardiomyopathies are classified as
HCM, RC, ARVD/c and DCM, with the etiologies related to Sarco-
mere, desmosomal proteins and Ryanodine receptor, components of
the cardiomyocytes. The present study included clinically confirmed
97 HCM, 86 DCM and 31 ARVD cases (213 patients) referred to
various hospitals in India. Mutational Screening of MYBPC3,
MYH7B, TNNI3, PKP2, RYR2 genes was carried out using SSCP
method followed by sequencing.
Following novel mutations were identified—(1) HCM—(a) In
MYBPC3 gene—frameshift mutation InsA11577^11578 in Exon19 in
one patient (b) In MYBPC3 gene—1 novel SNP C[T at 1093 codon
in exon 31 in one patient (2) ARVD—a. PKP2 gene—a frameshift
mutation 2 bp del-CT in exon 3.1 was identified in two patients. b.
RYR2 gene—Novel SNP A[C—5 bp upstream of acceptor splice
site in exon 8 identified in six patients and one control. c. RYR2
gene—novel SNP A[G at 1079 codon in exon 28—one patient d.
RYR2-Ins^G-30 bp downstream of exon 28 creating a cryptic splice
site (3) DCM—a. MYH7B gene—a G[C missense mutation at 377
codon in exon 12 in one patient b. MYH7B gene—a G[A missense
mutation at 787 codon in exon 21 in one patient c. TNNI3 gene—a
G[A missense mutation at 91 codon in exon 5 in one patient d.
TNNI3 gene—a G[C missense mutation at 74 codon in exon 5 in one
patient. In silico analysis revealed structural and functional alterations
of the sarcomeric and desmosomal proteins. Thus the present study
highlights the unique genetic variations in Indian population indi-
cating hotspot variations and implicating genes different from those
of western populations.
595: A High-throughput generation of flavonoid natural
product-inspired chemical probes: The discovery
of a novel class of cell motility inhibitor
1,2,3Jyoti Prokash Nandy, 1Bojana Rakic, 1Nallareddy Babu,
1Donald M. Leek, 2Kate Daniel, 2Luc A. Sabourin, 1,2,3Prabhat Arya
1Steacie Institute for Molecular Sciences, National Research Council
of Canada, 100 Sussex Drive, Ottawa, Ontario, K1A 0R6, Canada,
2Ottawa Health Research Institute, 503 Smyth Road, Ottawa,
ON, K1H 8L6, Canada, 3Ontario Institute for Cancer Research,
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With the growing interest in the use of small molecules as chemical
modulators of biomacromolecular interactions, a ready access to
natural product-inspired structurally complex compounds with
diverse architectures that could exhibit highly specific biological
responses comparable to bioactive natural products has also risen.
To address this need, we have developed a highly practical enan-
tioselective synthesis of a new class of benzofuran-derived cyclic
b-amino acids, which could further be utilized in generating a
diverse set of flavonoid-inspired, different bicyclic, tricyclic and
tetracyclic architectures. Through combining two important struc-
tural features (i.e., benzofuran scaffold and cyclic b-amino acid
functionality), we were interested in generating a variety of flavo-
noid-inspired small molecules and check their potency as
modulators of physiological processes; in particular, the protein
signaling network involved in cancer invasion. In one study, these
compounds were tested in a search for small molecule modulators
of cell migration using phenotypic assays. Our preliminary
screening efforts have identified a novel benzofuran-based
derivative as a modestly potent cell motility inhibitor (IC50
*40 lM by chamber cell migration assay).
597: Heterozygous I171 V mutation of the nibrin (NBN)
gene as a risk factor for solid malignant tumors
1Jerzy Nowak, 1Maria Mosor, 1Iwona Ziolkowska,
2Malgorzata Wierzbicka, 1Monika Pernak, 1Marta Przyborska,
2Krzysztof Roznowski, 1Andrzej Plawski, 1Ryszard Slomski,
1Danuta Januszkiewicz
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Strzeszynska 32 Poznan, Poland, 2University of Medical Sciences,
Poznan, Poland
Homozygous mutation 657del5 of the NBN gene is responsible for
the majority of Nijmegen breakage syndrome (NBS). Several studies
have focused on searching for an association between mutations in
the NBN gene and cancer incidence. Heterozygous carriers of the
NBN 657del5 mutation have been shown to have an increased risk
for breast cancer, melanoma, colon and rectum cancer. Other studies
have found no association between NBN gene mutations and
Hodgkin’s lymphoma or non-Hodgkin’s lymphoma. The aim of the
study was to analyse the frequency of another heterozygous mis-
sense I171 V mutation in NBN gene in 270 women with breast
cancer, 176 patients with larynx cancer, 81 with second primary
tumors of head and neck, 131 with colorectal carcinoma and 1274
healthy individuals. I171 V mutation was present in 17 cancer
patients compared with only 8 in healthy individuals. Since DNA
was isolated from non-malignant cells, all mutations found in cancer
patients appeared to be germinal origin. It can be concluded I171 V
mutation in NBSI gene is associated with predisposition to malig-
nancies and NBN allele I171 V may be a general cancer
susceptibiity gene.
598: Exploring the Indoline alkaloid natural
product-inspired space in a search of chemical probes
of FAK signaling networks
1Rajamohan Reddy Poondra, 2Michael Prakesch,
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Toronto, Ontario M5G 1L5, Canada
With the goals of identifying chemical probes of protein–protein
(p–p) interactions involved in signaling pathways, the research in our
group aims at developing methods leading to high-throughput gen-
eration of natural product-inspired compounds. Inspired by bioactive
indoline alkaloids that have a proven record of modulating p–p
interactions in many cases, we embarked a program that is aimed at
developing modular high-throughput approaches in producing dif-
ferent forms of polycyclic architectures varying in 3D shape and in
different display of chiral functional groups. These indoline-alkaloid
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insured compounds were engineered in a way that they could be
easily utilized in printing small molecule microarrays (in collabo-
ration with the chemical biology team at the Broad Institute). In
addition to this, the highly diverse indoline-alkaloid like collection
was also tested in a search of chemical probes of Focal Adhesion
Kinase (FAK) signaling networks in collaboration with the Lady
Davis Institute Team at McGill. FAK is an adapter protein and plays
a crucial role in regulating cell survival, proliferation, migration and
invasion in the development and progression of cancer. The over
expression of FAK is commonly found in a wide variety of human
cancers. Given its important role in a large number of biological
processes related to metastasis and survival signaling, FAK is
regarded as a potential target in the development of anti-cancer
drugs. This poster will highlight (1) the modular design and the
synthesis program in this area, (2) various solution and solid phase
methods developed to date, (3) the fabrication of small molecule
microchips utilizing these small molecules, and (4) the progress
made to date in the discovery of small molecule chemical modula-
tors of FAK activity.
599: A High-throughput generation of natural
product-inspired compounds: The discovery
of chemical modulators of cell death pathways involving
Bcl-XL/Mcl-1
1M. Prakesch, 2A. Denisov, 3M. Naim, 4A. Borodovsky,
4A. N. Koehler, 4J. Duffner, 4S. L. Schreiber, 2G. C. Shore,
2K. Gehring, 1P. Arya
1Ontario Institute for Cancer Research, MaRS Centre, 101 College
Street, Toronto M5G0A3, Canada, 2McGill University, Department of
Biochemistry, Montreal H3G1Y6, Canada, 3Biotechnology Research
Institute, NRC, Montreal H4P2R2, Canada, 4Broad Institute of
Harvard University and MIT, Chemical Biology Program,
Cambridge, MA 02142, United States of America
Bcl-2 is the founding member of a group of proteins that includes
anti-apoptosis proteins such as Bcl-2, Bcl-XL and Mcl-1 and pro-
apoptosis proteins such as Bax and Bak. Although Mcl-1 is a
homologous protein related to other anti-apoptotic proteins such as
Bcl-2 and Bcl-XL, it has a distinctly different structure and speci-
ficity for its binding to other pro-death Bcl-2 members. Cancer cells
that are highly resistant to small-molecule inhibitors of Bcl-2/Bcl-
XL can become highly sensitive when Mcl-1 activity is eliminated
by sRNAi, indicating the critical importance of inhibiting both Mcl-
1 and Bcl-XL/Bcl-2 for successful chemotherapy. Targeting Mcl-1
is therefore an important strategy in a search of a class of anti-
cancer agents based on overcoming the apoptosis resistance. With
the goals of identifying small molecule modulators of protein–
protein interactions, our group is developing high-throughput
methods leading to library generation of natural-product inspired
small molecules. In addition to testing these small molecules in
solution, they are also utilized in printing small molecule micro-
chips in collaboration with the Chemical Biology Program at the
Broad Institute. Through utilizing the small molecule microchip
technology, we identified a novel, natural product-inspired scaffold
as a small molecule binder to Mcl-1. This study then led us to
initiating collaboration with the Gehring team to carry-out low-
throughput screening of several analogs as small molecule binders
to Bcl-XL and Mcl-1 by NMR using the fragment-based approach.
This led us to identify a novel chiral tetrahydroquinoline scaffold as
a weak binder 200 UM to both Bcl-XL and Mcl-1. To our delight,
by simply making only nine derivatives of this scaffold, we were
able to discover the lead compound as a low uM binder to Mcl-1.
Interestingly, this compound also binds to Bcl-XL but with nearly
threefold less affinity.
600: Novel neurotrophic factors for the treatment
of neurodegenerative diseases
Mart Saarma
Institute of Biotechnology, University of Helsinki, Finland
Neurotrophic factors (NTF) are small secretory proteins that promote
differentiation and maintenance of neurons in developing and adult
vertebrate nervous system. NTFs can also protect degenerating
neurons in neurodegenerative diseases. In Parkinson’s disease there
is a progressive loss of functional dopaminergic neurons projecting
from substantia nigra to caudate putamen. The most potent NTF, the
glial cell line-derived neurotrophic factor (GDNF) delivery into the
putamen of Parkinsonian patients has resulted in significant clinical
improvement in some patients, but in double-blind clinical trial no
symptomatic improvement compared to placebo was reported. We
have identified a novel survival factor for dopaminergic neurons, the
conserved dopamine neurotrophic factor (CDNF), which was
strongly neuroprotective and neurorestorative in an experimental
model of Parkinson’s disease in rats. CDNF is a secreted protein
with eight conserved cysteine residues with the unique protein fold
and defining a novel, evolutionarily conserved neurotrophic factor
family. Other members of this family include the mesencephalic
astrocyte-derived neurotrophic factor (MANF) and invertebrate
MANFs. Our results demonstrate that CDNF might be beneficial for
the treatment of Parkinson’s disease.
601: In-silico designing of novel triazole derivatives
as substitute for novel fungicides
Sarika Sahu, Sandeep Kumar, Krishna Misra
Indian Intitute of Information Technology Allahabad, Devghat,
Jhalwa Allahabad, India
Sterol 14a-demethylase is an enzyme involved in metabolism of
endogenous and xenobiotic substances. The antifungal effect of
azoles is due to inhibition of sterol 14a demethylase in fungi, thereby
blocking the biosynthesis of ergosterol. The ergosterols provide
structure, modulation of membrane fluidity, and possibly controls
some physiologic events. Inhibition of this critical enzyme in the
ergosterol synthesis pathway leads to the depletion of ergosterol in the
cell membrane and accumulation of toxic intermediate sterols, caus-
ing increased membrane permeability and inhibition of fungal growth.
Due to the prolonged use of some marketed triazoles most of the
fungal infections have become resistant. This is mainly due to
acquired mutations by the fungi for self defence. Therefore there is
need to develop new modified fungicides which can specifically bind
to the sites involving mutation. We have used in silico methods to
design and screen some such novel triazole fungicides whose syn-
thesis is feasible in laboratory. Instead of synthesizing molecules for
hit and trial experiments, it is a much cost effective approach. The
synthesized triazoles can be field tested for their efficacy for the
resistant varieties.
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602: Predicting the activity and druggability
of compounds from medicinal plants through
in silico approach
Anjali Saxena, S. K. Gupta, Farhat N. Jaffery
Indian Institute of Toxicology Research, M.G. Marg, P.O. Box-80
Lucknow 226001, India
In silico approaches can help in identifying better drug candidates by
multiple screening methods. These bioactive components are
extracted from the medicinal plants and show their extensive bio-
logical action and used in treating several diseases like diffrent type of
cancers, neurotoxicity, skin diseases, diabetes and immune disorder
etc. Biological activities and druggability of these chemical com-
pounds are predicted against Lukemia by applying in silico tools.
Leukemia is a cancer of the white blood cells. There are two main
type of Leukemia: slower (called chronic) and faster growing (called
acute). High levels of exposure to radiation are known to increase
the risk of leukaemia. About 6,000 people in India and 6,755 cases in
the UK are diagnosed with leukemia and blood-related cancers. The
druggability of these compounds was checked by Lipinski’s scoring
function by calculating molecular weight (MW), LogP value, number
of hydrogen bond donor (Hdon) or hydrogen bond accepter (Hacc). In
the scoring function, if the predicted activity (Pa) of the lead com-
pound is [0.7, the substance is very likely to exhibit pharmaceutical
agent properties. Furthermore, targets for these bioactive compounds
have been screened out from disease pathway. Important genes/
enzymes, obtained in the crucial step of disease metabolism. The
binding sites on the target were complementary with their ligand in
term of volume, topology and physicochemical properties, only cer-
tain ligand have been bound to the target those had high binding
affinity. The ligand or bioactive compound must have the desired
physicochemical properties to be a better drug candidate. The result
of this In silico studies have identified important lead molecules from
12 medicinal plants used for the treatment of Leukemia on the basis of
their pharmaceutical and clinical properties.
603: RSA-14-44 interacts with PSMB5, a proteasome
subunit, in spermatogenic cells
1Wei Song, 1Ning Zhang, 1Yongqiang Tian, 1Shiying Miao,
2Shudong Zong, 1Linfang Wang
1National Laboratory of Medical Molecular Biology, Institute of
Basic Medical Sciences, Peking Union Medical College, Tsinghua
University, Beijing 100005, China, 2National Research Institute for
Family Planning WHO Collaboration Center for Research in Human
Reproduction, Beijing 100081, China
RSA-14-44 is a novel gene expressed exclusively in rat testis and has
previously been identified by suppressive subtractive hybridization
(SSH) between cDNAs of laser capture micro-dissection(LCM) trap-
ped rat primary spermatocytes and round spermatids. PSMB5, a
catalytic subunit of proteasome, is a protein that putatively interacts
with RSA-14-44 when screened by a yeast two hybrids assay of testis
cDNA library. Here we confirmed the occurrence of an interaction
between RSA-14-44 and PSMB5 by the GST-pull down and co-
immunoprecipitation assays. Moreover, the result of an immunofluo-
rescence experiment demonstrated that RSA-14-44 and PSMB5
showed exactly the same pattern of localization in a series of cells,
exemplifying different developmental stages of spermatogenesis. We
also found that RSA-14-44 is associated mainly with pro-type PSMB5,
based on a gradient sedimentation analysis, suggesting that it might be
involved in PSMB5 processing and that cysteine 190, a putative site
for palmitoylation modification in the C-terminal of RSA-14-44, is
required for mediating the interaction between RSA-14-44 and
PSMB5. Hence, the present findings suggests that RSA-14-44 is
involved in spermatogenesis through its interaction with PSMB5.
604: A novel PEG cross-linked PEI nanoparticle:
An efficient transfection agent in vitro and in vivo
Archana Swami, Pradeep Kumar, Kailash Chand Gupta
Institute of Genomic and Integrative Biology, Near Jubilee Hall,
Mall Road, Delhi, India
Gene therapy is a rapidly growing field of medicine in which genes are
introduced into the body to modify or replace the disease-causing
genes of certain cells in order to correct a genetic defect. Genetic
material such as DNA, RNA etc. have been used as molecular medi-
cine and are delivered to specific cell types with the aim to either
inhibit some undesirable gene expression or express therapeutic pro-
teins. The basic requirement in gene therapy is the effective gene
transfer followed by adequate gene expression. An ideal delivery
system for nucleic acids should be a nontoxic and non-immunogenic
that can protect nucleic acids during the delivery process, prevent
rapid elimination from the body, and release nucleic acid intracellu-
larly at the site of action. The serious drawbacks of the prevalent viral
delivery systems are related to security problems, severe immune or
inflammatory response, secondary oncogenesis and potential patho-
genicity because of the possible viral recombination. Hence the
development of biologically inactive non-viral methods have been
encouraged for gene delivery. Low immunogenecity, the absence of
endogenous recombination, low production costs, and reproducibility
are benifits of nonviral vectors, furthermore, they have no size limi-
tation in DNA packaging. Unfortunately, nonviral DNA delivery
vehicles often affect cell viability and have poor transfection effi-
ciency. In order to overcome these shortcomings, we have developed a
nanoparticulate carrier system, by covalently crosslinking Polyethy-
lenimine (PEI) with bisaldehyde-Polyethyleneglycol (bisald-PEG) and
further covalently coated the nanoparticles with hydrocarbon chains
with the aim of improving transfection efficiency and enhancing the
cell viability. The nanoparticles were characterised spectroscopically,
by AFM and DLS for size and morphology and zeta potential for
surface charge. The nanoparticles were tested in various cell lines for
the cytoxicity and were found to be nontoxic with enhanced trans-
fection efficiency (several folds compared to commercial transfection
agents). The proposed system was also found to deliver siRNA effi-
ciently into cells, resulting in*90% suppression of the targetted gene.
In summary bisald-PEG crosslinked PEI nanoparticles being virtually
nontoxic in the optimal concencentrations, and having good trans-
fection efficiency are promising non-viral vector for systemic in vivo
gene delivery.
605: Application of small molecule screening
to investigate binding specificity of protein families
Masoud Vedadi, Guillermo Senisterra, Gregory Wasney, Abdellah
Allali-Hassani, Patrick Finerty, Aled Edwards, Cheryl Arrowsmith
Structural Genomics Consortium, University of Toronto,
100 College Street, Toronto, Ontario, M5G 1L5, Canada
Availability of a generic screening method, which is not dependent on
the activity of proteins and can rapidly identify small molecules that
interact with proteins, greatly facilitates analysis of the binding
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specificity of individual members of any family of proteins. We have
employed various high throughput small molecule screening methods
to investigate the binding specificity of different members of families
of human proteins such as kinases and sulfotransferases. These
methods include differential static light scattering (DSLS), a label
free method, and differential scanning fluorimetry (DSF), a fluores-
cence based method. Creating chemical fingerprints for each protein
provides the opportunity to compare the small molecule binding
specificity of different members of each family and enables us to
identify potential inhibitors that bind to only a subset of proteins and
discriminate between different members. Using DSLS we have also
screened three membrane proteins: ABC transporter MsbA, Mg++
channel CorA and histidine kinase CpxA, and detected the stabilizing
effect of some ligands. We identified ligands, including ATP and its
analogues, for MsbA by screening it against a library of 38 selected
compounds and also detected the binding of Mg++ and ADP to CorA
and CpxA respectively. Combination of these available techniques
provide an opportunity to investigate protein-ligand interaction
genome-wide.
606: SPAG8, a testis specific protein, decreased the cell
proliferation and prolongated G2/M phase in cell cycle
1Hongyu Wu, 1Yongqing Han, 1Yingchun Chen, 1Xiaoling Tang,
2Shudong Zong, 1Shiying Miao, 1Linfang Wang
1National Laboratory of Medical Molecular Biology, Institute of
Basic Medical SciencesPeking Union Medical College, Tsinghua
University, 5 Dong Dan San Tiao, Beijing 100005, China, 2National
Research Institute for Family Planning, WHO Collaborating Center
for Research in Human Reproduction, 21 Hai Dian Da Hui Si,
Beijing 100081, China
SPAG8 is a testis-specific protein, the expression of which is highly
related to the progression of spermatogenesis. The distribution of
SPAG8 shows a phase-specific pattern in cell cycle, which could be
regulated by the interaction between SPAG8 and a-tubulin, a com-
ponent of microtubule. CHO-K1 cells expressing GFP-SPAG8 and
those expressing GFP were synchronized at early S phase by the
double thymidine block. After the release from the block, the tested
cells showed 16.9% in G2/M; in contrast to control cells having 4.1%
in G2/M phase while the remainder of 75.4% had progressed into G1
phase. The result of the flow cytometry assay showed that a G2/M
phase delay occurred in CHO-K1 cells stably expressing GFP-SPAG8,
during which the phosphorylation level of Tyr15 on Cdc2 was
increased significantly compared to that of CHO-K1 cells stably
expressing GFP. Furthermore, the results of MTT assay suggested the
cell proliferation of CHO-K1 cells stably expressing GFP-SPAG8 was
also retarded. Our findings demonstrate that SPAG8 might play an
important role in spermatogenesis through regulating the cell cycle of
spermatogenic cells based on its interaction with microtubules.
607: GADD153, a critical nodal point protein
in selenite-induced apoptosis of NB4 cells
Caimin Xu, Zhushi Li, Liying Guan, Yang Yang, Yun Ren,
Qian Jiang, Fang Huang
National Laboratory of Medical Molecular Biology, Institute of Basic
Medicine, Peking Union Medical College and Chinese Academy of
Medical Sciences, No. 5, Dongdan Santiao, Beijing, China
Selenium, an essential trace element possessing anti-carcinogenic
properties, can induce apoptosis in various cancer cells. Our previous
studies have discovered that 20 lM sodium selenite induced apop-
tosis of human acute promyelocytic leukemia NB4 cells, and
mitochondrial apoptotic pathway played a significant role in this
process. Based on those findings, the present study have found that
endoplasmic reticulum (ER) stress apoptotic pathway was also
involved in apoptosis of NB4 cells induced by sodium selenite. In the
early stage, sodium selenite induced activation of unfolded protein
response (UPR), which involves three pathways, PERK-eIF2a-ATF4,
IRE1-XBP1S and ATF6, thus initiated protective mechanisms against
ER stress to promote cell survival. However, as the stress level was
aggravated until too severe to be repaired, the apoptotic signals will
be triggered. GADD153 is a key pro-apoptosis transcription factor
that is closely related with ER stress. Selenite induced expression of
GADD153, while its specific siRNA remarkably inhibited cell
apoptosis induced by selenite, suggesting a critical role of GADD153
in selenite-induced apoptosis of NB4 cells. Our further study found
that selenite suppressed activation of anti-apoptotic kinase AKT,
while silencing of the expression of the GADD153 gene, DDIT3, by
siRNA prevented selenited-induced inactivation of AKT. Since acti-
vated AKT can induce phosphorylation of Bad, leading to inhibition
of mitochondrial apoptotic pathway, these data suggest that as a nodal
point protein, GADD153 can transmit signals from ER to mito-
chondria, linking ER stress apoptotic pathway and mitochondrial
apoptotic pathway together.
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